News

In case you missed them, we've compiled the top five infectious disease articles from this past week.

A large outbreak caused by the West African clade of the monkeypox virus has hit humans living in Nigeria.

A recent study finds no difference in risk for adverse birth outcomes between 3 antiretroviral regimens taken by pregnant women with HIV, including TDF-FTC-LPV/r, a regimen that has raised safety concerns in a past trial.

A recent study sheds light on how long Zika virus can be transmitted through semen following infection, while another study assessed the side effects of Zika infection on infants with post-natal exposure.

Investigational beta-lacatamase inhibitor IMI/REL demonstrates a favorable overall response against certain imipenem-non-susceptible bacterial infections.

Dr. Gonzalo Bearman delves into the use of contact precautions for endemic pathogens such as MRSA and VRE and assesses the effectiveness of this approach.

If this indication is approved, physicians will be able to reserve the vaccine for young children to protect them against the 2019-2020 flu season.

Data from the Behavioral Risk Factor Surveillance System indicate two-thirds of transgender men and women have not been tested for HIV/AIDS.

Should hospitals worry about severe weather events and their impact on infections?

Following outbreaks of measles and yellow fever in parts of Central America, South America, and the Caribbean, PAHO is leading the 16th annual Vaccination Week in the Americas in an effort to vaccinate 70 million individuals against several diseases.

Researchers present positive new data from multiple studies of VIBATIV at the 2018 ECCMID conference in Madrid, Spain.

A lesson from the recent Association of Health Care Journalists conference from one of the expert panelists, Contagion®’s very own, Saskia Popescu, MPH, MA, CIC.

If there are controlled substances at your facility, diversion is happening. What can be done to prevent future events?

This is the first Breakthrough Therapy designation for a MenB vaccine to help protect children as young as 1 year of age.

By studying norovirus infections in mice, researchers have discovered how the virus targets rare intestinal cells to cause intense illness.

Researchers present preliminary case series of confirmed cases of hepatitis A virus at Detroit Medical Center as Michigan struggles with ongoing outbreak.

In case you missed them, we’ve compiled a list of the latest recalls issued by the FDA and USDA.

According to recent research from Johns Hopkins Medicine, when it comes to making choices on appropriate antibiotic prescribing, outpatient providers are making the decision based on patient demand, not necessarily on what's actually appropriate for the condition.

The FDA has permitted marketing for a new use of the BRUKER MALDI Biotyper CA system to identify Candida auris.

Previously seen in Wisconsin in 2015-2016, Elizabethkingia seems to have made its way to the Empire state.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A recent survey explores prevention practices for Legionnaires’ disease and water management programs in health care facilities.

Dr. Thomas Sandora shares recent data on screening for asymptomatic carriage of Clostridium difficile and provides insight into what the preferred first-line treatment for the infection in children.

Kari Simonsen, MD, and Matthew Linam, MD debate the best way to measure and improve hand hygiene compliance.

In the SHEA Spring 2018 Opening Plenary, Zintars Beldavs stresses the importance of communication and collaboration in the fight against antimicrobial resistance.

Researchers compare CLABSIs attributed to CRE in short-term acute care hospitals with long-term acute care hospitals using data reported to NHSN in 2015-2016.

PIV infections are not as rigorously studied as CLABSIs, but they should be.

Women living with HIV are at elevated risk for comorbidities as their life expectancy increases.

Infections associated with the ongoing opioid epidemic in the United States apparently know no bounds.

In a recent webinar, epidemiologists from the Centers for Disease Control and Prevention presented data on Rocky Mountain Spotted Fever ahead of the summer tick season.